Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C12H14O3 |
| Molecular Weight | 206.2378 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1CC2=CC(CC(O)=O)=CC=C2O1
InChI
InChIKey=MYQXHLQMZLTSDB-UHFFFAOYSA-N
InChI=1S/C12H14O3/c1-2-10-7-9-5-8(6-12(13)14)3-4-11(9)15-10/h3-5,10H,2,6-7H2,1H3,(H,13,14)
| Molecular Formula | C12H14O3 |
| Molecular Weight | 206.2378 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0019371 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6475669 |
|||
Target ID: GO:0070527 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7359316 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of SAS 650 (Furofenac) on malondialydehyde production by platelets. | 1984-06 |
|
| Mass spectrometry of the metabolites of 2-ethyl-2,3-dihydro-5-benzofuranylacetic acid. | 1980-06 |
|
| Metabolites and analogs of 2-ethyl-2,3-dihydro-5-benzofuranacetic acid (furofenac): chemical and pharmacological properties. | 1980-02 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:35 GMT 2025
by
admin
on
Mon Mar 31 18:02:35 GMT 2025
|
| Record UNII |
86TB3JLD8A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
56983-13-2
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY | |||
|
DTXSID40866602
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY | |||
|
4509
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY | |||
|
260-500-1
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY | |||
|
42091
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY | |||
|
C65787
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY | |||
|
100000084502
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY | |||
|
SUB07846MIG
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107650
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY | |||
|
86TB3JLD8A
Created by
admin on Mon Mar 31 18:02:35 GMT 2025 , Edited by admin on Mon Mar 31 18:02:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |